313 related articles for article (PubMed ID: 23302310)
21. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Rosa M; Mohammadi A; Masood S
Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
Fadare O
Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of pure tubular and tubulolobular carcinoma of the breast.
Green I; McCormick B; Cranor M; Rosen PP
Am J Surg Pathol; 1997 Jun; 21(6):653-7. PubMed ID: 9199642
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
27. High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients.
Vincent-Salomon A; Hajage D; Rouquette A; Cédenot A; Gruel N; Alran S; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Kirova Y
Breast; 2012 Jun; 21(3):380-3. PubMed ID: 22531230
[TBL] [Abstract][Full Text] [Related]
28. Invasive lobular carcinoma in a hypoplastic breast.
Bassarova AV; Sedloev T; Christova SL; Trifonov DY; Nesland JM
Ultrastruct Pathol; 2002; 26(6):411-4. PubMed ID: 12537766
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].
Zheng S; Zhang BL; Xiao T; Zou SM; Xue LY; Luo W; Guo L; Liu XY; Lü N
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):465-70. PubMed ID: 22088373
[TBL] [Abstract][Full Text] [Related]
30. An analysis of prognostic features in infiltrating lobular carcinoma of the breast.
Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG
Mod Pathol; 1995 Oct; 8(8):830-6. PubMed ID: 8552571
[TBL] [Abstract][Full Text] [Related]
31. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation.
Qayyum A; Birdwell RL; Daniel BL; Nowels KW; Jeffrey SS; Agoston TA; Herfkens RJ
AJR Am J Roentgenol; 2002 May; 178(5):1227-32. PubMed ID: 11959737
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma.
Harbhajanka A; Lamzabi I; Syed S; Jain R; Ghai R; Reddy VB; Bitterman P; Gattuso P
Appl Immunohistochem Mol Morphol; 2016; 24(10):738-743. PubMed ID: 26574630
[TBL] [Abstract][Full Text] [Related]
35. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathologic study of solid papillary carcinoma of breast].
Wei B; Bu H; Chen HJ; Zhang HY; Li XJ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):589-93. PubMed ID: 17134565
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
38. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
39. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
[TBL] [Abstract][Full Text] [Related]
40. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.
Shin SJ; DeLellis RA; Ying L; Rosen PP
Am J Surg Pathol; 2000 Sep; 24(9):1231-8. PubMed ID: 10976697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
